2 completed, 1 recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
Follow Mental Disorder: new trials by email Literature Review of Mental Disorder trials Research Report on Mental Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dexmedetomidine and Magnesium Sulfate in the Reduction Cognitive Dysfunction in Geriatrics dexmedetomidine - Mental Disorder | Phase 1 | Recruiting | Fayoum University | 58 | 2024-11-21 | 2024-11-25 |
| Neuroimmune Dysfunction in Alcohol Use Disorder Minocycline, Sugar pill - Alcohol Drinking, Alcohol-Related Disorders | Phase 1 | Completed | University of Maryland, Baltimore | 142 | 2020-02-03 | 2023-12-01 |
| Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia Aripiprazole, OPC-14597 - Schizophrenia, Mental Disorder | Phase 1 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 141 | 2013-07-01 | 2015-07-01 |
Mental Disorders (3) · Alcohol Drinking (1) · Alcohol-Related Disorders (1) · Alcoholism (1) · Chemically-Induced Disorders (1) · Cognition Disorders (1) · Cognitive Dysfunction (1) · Disease (1) · Drinking Behavior (1) · Inflammation (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Pathologic Processes (1) · Schizophrenia (1) · Substance-Related Disorders (1)
Behavior (1) · Pathological Conditions, Signs and Symptoms (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1)
Aripiprazole (1) · Dexmedetomidine (1) · Magnesium Sulfate (1) · Minocycline (1) · Sugars (1)
Fayoum University (1) · Otsuka Pharmaceutical Development & Commercialization, Inc. (1) · University of Maryland, Baltimore (1)
United States (2) · Egypt (1)
PMID 13243706, PMID 28204607, PMID 40483726
K01AA026005 (1)